Biophan files broad patent on use of nanotubes for drug delivery
US-based Biophan Technologies, a developer of next-generation medical technology, has filed a broad patent as part of its collaboration with strategic partner NaturalNano on novel drug delivery technologies involving applications of naturally occurring nanotubes found in halloysite clay.
US-based Biophan Technologies, a developer of next-generation medical technology, has filed a broad patent as part of its collaboration with strategic partner NaturalNano on novel drug delivery technologies involving applications of naturally occurring nanotubes found in halloysite clay.
Biophan and NaturalNano are collaborating to develop products using the nanotubes as advanced drug delivery systems in a number of proprietary biomedical applications. Biophan's newly filed patent application covers biomedical uses of the nanotubes for a range of products, including bandages, wound healing applications and other uses.
Under a previously reached agreement between the companies, Biophan holds the worldwide exclusive rights to NaturalNano's nanotube technologies for the medical and pharmaceutical markets. NaturalNano is working with Biophan's drug delivery division, Nanolution, to develop and market the nanotube-based technologies.
'NaturalNano's halloysite-derived nanotubes have unique properties that make them extremely promising for development in biomedical applications,' said John Lanzafame, president of Biophan's Nanolution division 'We believe this partnership with NaturalNano will lead to a new class of long lasting controlled release agents for drugs and other materials, in medical device coatings and for pharmaceutical compounds.'